RECURSION PHARMACEUTICALS-A
RXRXNASDAQ🏆 #1948 by market capEarnings Nov 4US Equity
$3.30▼ $0.05 (−1.64%)
Live1h▲ 0.3%
24h▼ 1.6%
7d▲ 3.6%
14d▲ 11.3%
30d▼ 0.2%
1y▼ 39.2%
🏦Market Cap
$1.73B
Small Cap
📈Revenue Growth (YoY)
+26.9%
High Growth
📊Gross Margin
-46.7%
Thin
💵FCF Margin
-790.5%
Thin
⚖️P/S Ratio
32.0x
Expensive
Otter Score
60
Fair
📊
Analyst Ratings
Price
$3.30
Total
10
Raised
0
Lowered
0
Avg PT
$5.50
H / L
$6 / $6
| Institution | Action | Rating | Date |
|---|---|---|---|
Morgan Stanley | Reiterated | Equal Weight | 2026-05-14 |
Needham | Reiterated | Buy | 2026-05-07 |
JP Morgan | Reiterated | Overweight | 2026-04-30 |
B of A Securities | Reiterated | Neutral | 2026-02-26 |
Leerink Partners | Reiterated | Market Perform | 2025-02-28 |
Keybanc | Reiterated | Overweight | 2025-01-08 |
Jefferies | Reiterated | Hold | 2024-09-03 |
Berenberg | Reiterated | Buy | 2023-07-12 |
SVB Leerink | Reiterated | Market Perform | 2023-01-23 |
Goldman Sachs | Reiterated | Neutral | 2022-11-09 |
One row per institution, most recent rating